Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma.
about
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomasResponse of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapiesOncogenic mutations of PIK3CA in human cancersGenomic and molecular characterization of esophageal squamous cell carcinomaThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsReverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients.Up-regulation of PIK3CA promotes metastasis in gastric carcinoma.A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma.Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, ChinaRole of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse modelsAloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagusPIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients.Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib.Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis.Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma.Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.Increased Expression of Phosphatidylinositol 3-Kinase p110α and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma.
P2860
Q24336818-4962E145-D0FB-43AE-83EC-774B786CF5FCQ27853149-BE292670-0EA4-4C59-AFEB-17E62911E87CQ28284802-DB293936-CB2A-4F95-9ACB-1D53A5F99C70Q28657686-1EAF3966-C266-4E4C-9995-81EE6D123388Q30365726-3B0E6333-21C3-4C77-841C-B7E705004291Q33637161-E8C77B3C-26D3-4C10-B652-EE4424B63F42Q33940350-F45D1665-750A-4F68-9B5A-6F1A0BBCE92EQ34109055-53EC907B-980E-441E-A267-9FF577F14AD6Q34213783-2E6C93F8-B6F0-4B30-AE36-FCD2FF53C435Q34388422-1ACA927C-F906-4DF1-B62D-B7DC9BBC6004Q34392987-24F57CD2-6078-49D0-B118-1EB2BD60DC77Q35883001-AB9168E0-2715-45A1-BF19-E918CDD256E4Q35994228-0FA34030-F66D-474A-93E7-91B4A3A9C7D1Q36244592-AE44828F-FF82-44AA-B352-4D843B222B2AQ36361515-43EF756A-DF35-4328-8A2A-D8A0A1E643EFQ37206000-367478D8-E0C8-46AF-AB87-0C69613DFEF9Q37327580-8AA641D2-B1E7-4B78-A92F-44730AAF8D06Q37609759-4C8287A9-7644-45EC-9D67-A2184021A608Q37728444-ED64FB11-E38F-4D8C-81FF-7596C9D97EA2Q45334548-7E12673D-2EE4-48D7-BF78-6311906F9E43Q48513587-2902E0F1-448C-4859-BDF9-874CEFC045DFQ53176024-6BE56058-2F6A-4917-9C9F-DCC51138EB07Q53206186-5C5D6C7A-070D-4DDF-9411-2B070EA8BCBFQ53220241-215A32AF-A246-4990-80E2-5CBAC119A098Q53246835-E3FF29F1-2C86-43B5-BCE6-5EA5F9269D03Q54351962-079DCC5A-0EF8-430C-8A89-8C1AFD599373Q54583226-0FF5DC3D-D3FF-42DF-8D65-851BDB976096Q55036376-018971F8-09C8-4360-9255-5BE82E307583
P2860
Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@en
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@nl
type
label
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@en
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@nl
prefLabel
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@en
Overexpression of PIK3CA is as ...... ageal squamous cell carcinoma.
@nl
P2093
P356
P1476
Overexpression of PIK3CA is as ...... hageal squamous cell carcinoma
@en
P2093
Hiroshi Makino
Ichiro Akagi
Kazumitsu Cho
Ken Takahashi
Masao Miyashita
Nobutoshi Hagiwara
Takashi Tajiri
Takuya Mishima
Toshihiro Takizawa
Tsutomu Nomura
P304
P356
10.3892/IJO_00000202
P577
2009-03-01T00:00:00Z